Antibacterial Antifolates: From Development through Resistance to the Next Generation

Area of Science:

• Microbiology
• Drug Discovery
• Biochemistry

Background:

• The folate cycle is crucial for bacterial survival and proliferation, making its enzymes key targets for antibiotics.
• Trimethoprim and sulfamethoxazole are widely used antibacterials targeting the folate pathway against Gram-positive and Gram-negative bacteria.
• Emerging antibiotic resistance poses a significant threat to the clinical utility of these vital drugs.

Purpose of the Study:

• To analyze clinically observed resistance mechanisms against folate pathway inhibitors.
• To review emerging preclinical compounds designed to overcome antibiotic resistance.
• To provide insights into strategies for maintaining the efficacy of essential antibacterial agents.

Main Methods:

• Literature review of clinically observed resistance mechanisms.
• Analysis of molecular basis of resistance.
• Review of preclinical drug development targeting the folate pathway.

Main Results:

• Identified and analyzed various clinically observed resistance mechanisms against folate pathway inhibitors.
• Highlighted the molecular basis underlying antibiotic resistance.
• Presented an overview of novel preclinical compounds and their resistance-breaking potential.

Conclusions:

• Understanding resistance mechanisms is critical for developing effective antibacterial strategies.
• Newer preclinical compounds show promise in overcoming existing resistance.
• Continued research is essential to combat evolving antibiotic resistance and preserve treatment options.